HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CMS

12.870

-0.400-3.01%

Volume:3.70M

Turnover:47.90M

Market Cap:31.40B

PE:18.48

High:13.370

Open:13.250

Low:12.780

Close:13.270

52wk High:15.630

52wk Low:6.649

Shares:2.44B

HK Float Shares:2.44B

Volume Ratio:0.91

T/O Rate:0.15%

Dividend:0.33

Dividend Rate:2.57%

EPS(LYR):0.697

ROE:8.50%

ROA:5.30%

PB:1.59

PE(LYR):18.48

PS:3.38

Loading ...

Overview Company News Filings

CICC Maintains "Outperform" Rating on CMS (00867), Raises Target Price to HK$16.5

China Medical System Holdings Limited Approval of Clinical Trials for Pnh of Innovative Drug Complement Factor B Inhibitor CMS-D017

THOMSON REUTERS

China Medical System - CMS-D017 Capsules Obtain Drug Clinical Trial Approval From Nmpa

THOMSON REUTERS

China Medical System Holdings Receives NMPA Approval to Begin Clinical Trials for CMS-D017

China Medical System Unit Secures New Drug Application Approval in China for Vitiligo Drug

MT Newswires Live

CMS (00867): Innovative Drug Ruxolitinib Phosphate Cream Approved in China, Marking First and Only Targeted Therapy for Vitiligo

China Medical System Holdings - New Drug Application of Ruxolitinib Phosphate Cream Approved in China

THOMSON REUTERS

China Medical System Holdings Wins NMPA Approval for Ruxolitinib Cream for Vitiligo

With 51% ownership, China Medical System Holdings Limited (HKG:867) insiders have a lot riding on the company's future

Simply Wall St.

CMS Securities Initiates Coverage on CMS (00867) with "Strongly Recommend" Rating, Citing Innovation and Internationalization Driving Commercial Leader into New Phase

An Insider At China Medical System Holdings Lowered Their Holding Recently

Simply Wall St.

China Medical System Holdings (SEHK:867): Valuation Check After Y-3 Stroke Drug NDA Acceptance and Phase III Success

Simply Wall St.

Guoyuan International Initiates "Buy" Rating on CMS (00867) with Target Price of HK$17.68

Dermavon Secures Breakthrough Drug Status for Oral JAK1 Inhibitor in China

CMS (00867): Innovative Oral JAK1 Inhibitor Povorcitinib Included in Breakthrough Therapy List

China Medical System's Povorcitinib Listed as Breakthrough Therapeutic Drug by China NMPA

What China Medical System Holdings (SEHK:867)'s Stroke Drug NDA Acceptance Means For Shareholders

Simply Wall St.

CMS (00867): China's NMPA Accepts New Drug Application for Class 1 Innovative Drug Y-3 Injection for Acute Ischemic Stroke

China Medical System - Nda of Class 1 Innovative Drug Y-3 for Injection Accepted by China's Nmpa

THOMSON REUTERS

China Medical System's New Drug Application for Y-3 Injection Accepted in China

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/00867/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"00867","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00867\",,,,,undefined,":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"CMS","latestPrice":12.87,"timestamp":1774512497003,"preClose":13.27,"halted":0,"volume":3697025,"delay":0,"changeRate":-0.03014318010550116,"floatShares":2439528512,"shares":2440000000,"eps":0.6966062015382568,"marketStatus":"Closed","change":-0.4,"latestTime":"03-26 16:08:17","open":13.25,"high":13.37,"low":12.78,"amount":47904934,"amplitude":0.044461,"askPrice":12.87,"askSize":4000,"bidPrice":12.83,"bidSize":6000,"shortable":3,"etf":0,"ttmEps":0.6966062015382568,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774575000000},"marketStatusCode":5,"adr":0,"listingDate":1285603200000,"exchange":"SEHK","adjPreClose":13.27,"dividendRate":0.025783,"openAndCloseTimeList":[[1774488600000,1774497600000],[1774501200000,1774512000000]],"volumeRatio":0.908206,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00867\",,,,,undefined,":{"symbol":"00867","floatShares":2439528512,"roa":"5.30%","roe":"8.50%","lyrEps":0.696606,"volumeRatio":0.908206,"shares":2440000000,"dividePrice":0.330645,"high":13.37,"amplitude":0.044461,"preClose":13.27,"low":12.78,"week52Low":6.649,"pbRate":"1.59","psRate":"3.38","week52High":15.63,"institutionHeld":0,"latestPrice":12.87,"committee":0.2,"eps":0.6966062015382568,"divideRate":0.025691,"volume":3697025,"delay":0,"ttmEps":0.6966062015382568,"open":13.25,"prevYearClose":12.9,"prevWeekClose":13.49,"prevMonthClose":14.6,"prevQuarterClose":12.9,"fiveDayClose":13.59,"twentyDayClose":14.63,"sixtyDayClose":13.06,"dividendGrowthYears":1,"dividendGrowthRate":0.19199999999999995,"fiveYearAvgDividendRate":0.042685480928976144},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/00867\",params:#limit:5,,,undefined,":[{"date":"2026-04-27","symbol":"00867","amount":0.155,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-28","defaultRemindTime":1777253400000,"name":"康哲药业","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-07","payableDate":"2026-04-28","currency":"HKD","dateTimestamp":1777219200000,"payDate":"2026-05-07"},{"date":"2026-03-16","symbol":"00867","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773624600000,"name":null,"time":"","dateTimestamp":1773590400000,"actualEps":null},{"date":"2025-08-29","symbol":"00867","amount":0.171,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-09-01","defaultRemindTime":1756431000000,"name":"康哲药业","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-09","payableDate":"2025-09-01","currency":"HKD","dateTimestamp":1756396800000,"payDate":"2025-09-09"},{"date":"2025-08-18","symbol":"00867","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-04-28","symbol":"00867","amount":0.127,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-04-29","defaultRemindTime":1745803800000,"name":"康哲药业","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-09","payableDate":"2025-04-29","currency":"HKD","dateTimestamp":1745769600000,"payDate":"2025-05-09"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"00867\",market:\"HK\",,,undefined,":[{"executeDate":"2016-04-26","recordDate":"2016-04-27","paymentDate":"2016-05-09","value":0.097,"currency":"HKD"},{"executeDate":"2016-09-02","recordDate":"2016-09-05","paymentDate":"2016-09-15","value":0.122,"currency":"HKD"},{"executeDate":"2017-04-28","recordDate":"2017-05-02","paymentDate":"2017-05-12","value":0.131,"currency":"HKD"},{"executeDate":"2017-04-30","recordDate":"2017-05-02","paymentDate":"2017-05-12","value":0.1164,"currency":"CNY"},{"executeDate":"2017-09-04","recordDate":"2017-09-05","paymentDate":"2017-09-13","value":0.152,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"00867\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.625,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1771948800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/00867\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"00867","date":"2026-03-25","current":18.475288,"percent":0.974817,"low":5.884184,"twenty":7.823631,"median":9.172521,"eighty":14.901444,"high":20.673017,"avg":11.01266,"sd":3.91605,"marketCap":32120061540},"quantilePoints":[{"date":"2021-03-26","current":13.122227,"twenty":9.553858,"median":12.409218,"eighty":13.316652,"marketCap":39433337771},{"date":"2021-04-01","current":13.58539,"twenty":9.613981,"median":12.488983,"eighty":13.32105,"marketCap":40718133237},{"date":"2021-04-09","current":13.604823,"twenty":9.746185,"median":12.507712,"eighty":13.530618,"marketCap":40866378868},{"date":"2021-04-16","current":13.684615,"twenty":9.852182,"median":12.568872,"eighty":13.530618,"marketCap":41261700550},{"date":"2021-04-23","current":14.876539,"twenty":10.06422,"median":12.707742,"eighty":13.713581,"marketCap":44967841318},{"date":"2021-04-30","current":14.652659,"twenty":10.278778,"median":12.859699,"eighty":14.076504,"marketCap":44473689216},{"date":"2021-05-07","current":13.895117,"twenty":10.388789,"median":12.968028,"eighty":14.185456,"marketCap":42447665596},{"date":"2021-05-14","current":14.163152,"twenty":10.734805,"median":13.050434,"eighty":14.167647,"marketCap":43238308960},{"date":"2021-05-21","current":15.664175,"twenty":10.974172,"median":13.113611,"eighty":14.233301,"marketCap":47833923512},{"date":"2021-05-28","current":15.511335,"twenty":11.168288,"median":13.171522,"eighty":14.407617,"marketCap":47833923512},{"date":"2021-06-04","current":16.744452,"twenty":11.46576,"median":13.310055,"eighty":14.683181,"marketCap":51391818649},{"date":"2021-06-11","current":17.591009,"twenty":11.638077,"median":13.379751,"eighty":14.865024,"marketCap":53986117187},{"date":"2021-06-18","current":16.720252,"twenty":11.723049,"median":13.494104,"eighty":15.065376,"marketCap":50897666547},{"date":"2021-06-25","current":17.218086,"twenty":11.809938,"median":13.644719,"eighty":15.463043,"marketCap":52380122854},{"date":"2021-07-02","current":16.255639,"twenty":11.98984,"median":13.701632,"eighty":15.771994,"marketCap":49365795029},{"date":"2021-07-09","current":14.936308,"twenty":12.070602,"median":13.769163,"eighty":15.771994,"marketCap":45313747790},{"date":"2021-07-16","current":15.425273,"twenty":12.160369,"median":13.888008,"eighty":15.664175,"marketCap":46796204097},{"date":"2021-07-23","current":14.62854,"twenty":12.201704,"median":14.006703,"eighty":15.596098,"marketCap":44374858795},{"date":"2021-07-30","current":12.793641,"twenty":12.236121,"median":13.919723,"eighty":15.574104,"marketCap":38939185669},{"date":"2021-08-06","current":13.833652,"twenty":12.3431,"median":13.833652,"eighty":15.511335,"marketCap":42002928704},{"date":"2021-08-13","current":13.81483,"twenty":12.475337,"median":13.845344,"eighty":15.500024,"marketCap":42002928704},{"date":"2021-08-20","current":13.348823,"twenty":12.480339,"median":13.836105,"eighty":15.468029,"marketCap":40471057186},{"date":"2021-08-27","current":10.480685,"twenty":12.224513,"median":13.817343,"eighty":15.425273,"marketCap":36305479526},{"date":"2021-09-03","current":11.39284,"twenty":12.070602,"median":13.769163,"eighty":15.422096,"marketCap":39481256192},{"date":"2021-09-10","current":11.059867,"twenty":11.588415,"median":13.731918,"eighty":15.269873,"marketCap":38425927936},{"date":"2021-09-17","current":10.700706,"twenty":11.161167,"median":13.703997,"eighty":15.264251,"marketCap":37068118100},{"date":"2021-09-24","current":9.968358,"twenty":11.052791,"median":13.694964,"eighty":15.191233,"marketCap":34547179878},{"date":"2021-09-30","current":10.062665,"twenty":10.907007,"median":13.676872,"eighty":15.169991,"marketCap":34990724270},{"date":"2021-10-08","current":9.978083,"twenty":10.756241,"median":13.570974,"eighty":15.155811,"marketCap":34695028008},{"date":"2021-10-15","current":10.240354,"twenty":10.511076,"median":13.485881,"eighty":15.12437,"marketCap":35631399503},{"date":"2021-10-22","current":10.097043,"twenty":10.427452,"median":13.348823,"eighty":15.083334,"marketCap":35384985952},{"date":"2021-10-29","current":9.346704,"twenty":10.284705,"median":13.310055,"eighty":15.05651,"marketCap":32674436889},{"date":"2021-11-05","current":8.937482,"twenty":10.238528,"median":13.171522,"eighty":15.02909,"marketCap":31295353232},{"date":"2021-11-12","current":9.161853,"twenty":10.20165,"median":13.135817,"eighty":15.011949,"marketCap":32213273507},{"date":"2021-11-19","current":9.140925,"twenty":10.076416,"median":13.076627,"eighty":14.967375,"marketCap":32094212266},{"date":"2021-11-26","current":9.27794,"twenty":9.938275,"median":13.001205,"eighty":14.931251,"marketCap":32585700969},{"date":"2021-12-03","current":8.799872,"twenty":9.830934,"median":12.919052,"eighty":14.917268,"marketCap":30963788251},{"date":"2021-12-10","current":9.007979,"twenty":9.579658,"median":12.802053,"eighty":14.895218,"marketCap":31750170175},{"date":"2021-12-17","current":8.860717,"twenty":9.424367,"median":12.707742,"eighty":14.865024,"marketCap":31209532602},{"date":"2021-12-24","current":9.200778,"twenty":9.319647,"median":12.568872,"eighty":14.806832,"marketCap":32438254358},{"date":"2021-12-31","current":9.055615,"twenty":9.275386,"median":12.514971,"eighty":14.73971,"marketCap":31995914526},{"date":"2022-01-07","current":9.006348,"twenty":8.990763,"median":9.055615,"eighty":9.381863,"marketCap":31701021304},{"date":"2022-01-14","current":9.934219,"twenty":9.002537,"median":9.376516,"eighty":9.880149,"marketCap":35043144481},{"date":"2022-01-21","current":10.064441,"twenty":9.035908,"median":9.487625,"eighty":9.936468,"marketCap":35583782053},{"date":"2022-01-28","current":8.919509,"twenty":8.990763,"median":9.410956,"eighty":9.897378,"marketCap":31455276953},{"date":"2022-02-04","current":9.160924,"twenty":8.99682,"median":9.376516,"eighty":9.872817,"marketCap":32290807747},{"date":"2022-02-11","current":9.309443,"twenty":9.006348,"median":9.335772,"eighty":9.844103,"marketCap":32880594190},{"date":"2022-02-18","current":9.499351,"twenty":9.040115,"median":9.376516,"eighty":9.828738,"marketCap":33716124984},{"date":"2022-02-25","current":9.614125,"twenty":9.055615,"median":9.467289,"eighty":9.775653,"marketCap":34207613687},{"date":"2022-03-04","current":9.320472,"twenty":9.09274,"median":9.445241,"eighty":9.766198,"marketCap":33175487412},{"date":"2022-03-11","current":8.781406,"twenty":9.000375,"median":9.388812,"eighty":9.720392,"marketCap":31209532602},{"date":"2022-03-18","current":8.343913,"twenty":8.955567,"median":9.330652,"eighty":9.676872,"marketCap":30962150251},{"date":"2022-03-25","current":8.317076,"twenty":8.802476,"median":9.309443,"eighty":9.664439,"marketCap":30863857710},{"date":"2022-04-01","current":8.148458,"twenty":8.60906,"median":9.228473,"eighty":9.654518,"marketCap":30274102467},{"date":"2022-04-08","current":7.824409,"twenty":8.54677,"median":9.132904,"eighty":9.622204,"marketCap":29082751982},{"date":"2022-04-14","current":7.793529,"twenty":8.356591,"median":9.074177,"eighty":9.590797,"marketCap":28920059171},{"date":"2022-04-22","current":7.497009,"twenty":8.303779,"median":9.023231,"eighty":9.567084,"marketCap":27299750253},{"date":"2022-04-29","current":7.779976,"twenty":8.027734,"median":8.99682,"eighty":9.554488,"marketCap":27874185496},{"date":"2022-05-06","current":7.331113,"twenty":7.782687,"median":8.969656,"eighty":9.545856,"marketCap":26047817497},{"date":"2022-05-13","current":7.773946,"twenty":7.655668,"median":8.919509,"eighty":9.513457,"marketCap":27127011442},{"date":"2022-05-20","current":7.721834,"twenty":7.655668,"median":8.844963,"eighty":9.499351,"marketCap":27323228523},{"date":"2022-05-27","current":7.562034,"twenty":7.562034,"median":8.709782,"eighty":9.49463,"marketCap":26734577280},{"date":"2022-06-02","current":7.369852,"twenty":7.560574,"median":8.60906,"eighty":9.489026,"marketCap":26194980308},{"date":"2022-06-10","current":7.91994,"twenty":7.560574,"median":8.554509,"eighty":9.471356,"marketCap":27960934036},{"date":"2022-06-17","current":7.984273,"twenty":7.563884,"median":8.43871,"eighty":9.432011,"marketCap":28157151117},{"date":"2022-06-24","current":8.645347,"twenty":7.60126,"median":8.438023,"eighty":9.403614,"marketCap":30609864629},{"date":"2022-06-30","current":8.493713,"twenty":7.637596,"median":8.465396,"eighty":9.392775,"marketCap":30021213386},{"date":"2022-07-08","current":8.651351,"twenty":7.655795,"median":8.494931,"eighty":9.368111,"marketCap":30609864629},{"date":"2022-07-15","current":8.49438,"twenty":7.657802,"median":8.494655,"eighty":9.343188,"marketCap":29775942035},{"date":"2022-07-22","current":8.810462,"twenty":7.666078,"median":8.553465,"eighty":9.329628,"marketCap":30904190251},{"date":"2022-07-29","current":8.72989,"twenty":7.671519,"median":8.5747,"eighty":9.322496,"marketCap":30658918900},{"date":"2022-08-05","current":8.500119,"twenty":7.683934,"median":8.553465,"eighty":9.313855,"marketCap":29775942035},{"date":"2022-08-12","current":8.866131,"twenty":7.696536,"median":8.558629,"eighty":9.309229,"marketCap":31100407332},{"date":"2022-08-19","current":8.503747,"twenty":7.701421,"median":8.590833,"eighty":9.301248,"marketCap":29530670684},{"date":"2022-08-26","current":7.99005,"twenty":7.696536,"median":8.557061,"eighty":9.214963,"marketCap":29089182252},{"date":"2022-09-02","current":7.761913,"twenty":7.701421,"median":8.51999,"eighty":9.160775,"marketCap":28157151117},{"date":"2022-09-09","current":7.452221,"twenty":7.671519,"median":8.497525,"eighty":9.127349,"marketCap":26930794361},{"date":"2022-09-16","current":7.179204,"twenty":7.655752,"median":8.494046,"eighty":9.100175,"marketCap":25704437605},{"date":"2022-09-23","current":6.767616,"twenty":7.557654,"median":8.440917,"eighty":9.07789,"marketCap":23765631131},{"date":"2022-09-30","current":6.530514,"twenty":7.496719,"median":8.40119,"eighty":9.049415,"marketCap":22976818957},{"date":"2022-10-07","current":6.44725,"twenty":7.494534,"median":8.350058,"eighty":9.034674,"marketCap":22682558736},{"date":"2022-10-14","current":6.734259,"twenty":7.478814,"median":8.311302,"eighty":9.011598,"marketCap":23441010174},{"date":"2022-10-21","current":7.014756,"twenty":7.444746,"median":8.290132,"eighty":9.005153,"marketCap":24250166383},{"date":"2022-10-28","current":6.394451,"twenty":7.382505,"median":8.256533,"eighty":8.999664,"marketCap":22067896608},{"date":"2022-11-04","current":6.783161,"twenty":7.324162,"median":8.141695,"eighty":8.993792,"marketCap":23637169255},{"date":"2022-11-11","current":6.779041,"twenty":7.222943,"median":8.066515,"eighty":8.979274,"marketCap":23833328336},{"date":"2022-11-18","current":7.362207,"twenty":7.222943,"median":7.992882,"eighty":8.967801,"marketCap":25794919146},{"date":"2022-11-25","current":6.807362,"twenty":7.153128,"median":7.984273,"eighty":8.960032,"marketCap":23661689140},{"date":"2022-12-02","current":7.683514,"twenty":7.153128,"median":7.946637,"eighty":8.958027,"marketCap":27168032712},{"date":"2022-12-09","current":9.069403,"twenty":7.181175,"median":7.978631,"eighty":8.967801,"marketCap":32366248358},{"date":"2022-12-16","current":8.718719,"twenty":7.192758,"median":7.987248,"eighty":8.967801,"marketCap":31042174561},{"date":"2022-12-23","current":8.302923,"twenty":7.209749,"median":8.017354,"eighty":8.960032,"marketCap":29570981454},{"date":"2022-12-30","current":8.352905,"twenty":7.216324,"median":8.04422,"eighty":8.958989,"marketCap":30110418927},{"date":"2023-01-06","current":8.766197,"twenty":7.231797,"median":8.108994,"eighty":8.956797,"marketCap":31924890426},{"date":"2023-01-13","current":9.037721,"twenty":7.251553,"median":8.148458,"eighty":8.96409,"marketCap":33543202844},{"date":"2023-01-20","current":9.275875,"twenty":7.283666,"median":8.206086,"eighty":9.002764,"marketCap":34131680087},{"date":"2023-01-27","current":9.540471,"twenty":7.300229,"median":8.242382,"eighty":9.01291,"marketCap":35112475491},{"date":"2023-02-03","current":9.146664,"twenty":7.3071,"median":8.278352,"eighty":9.040115,"marketCap":33837441465},{"date":"2023-02-10","current":8.948571,"twenty":7.312196,"median":8.298789,"eighty":9.037721,"marketCap":32905685831},{"date":"2023-02-17","current":8.603187,"twenty":7.322424,"median":8.311302,"eighty":9.037721,"marketCap":31336413183},{"date":"2023-02-24","current":8.396176,"twenty":7.324845,"median":8.330495,"eighty":9.036589,"marketCap":30208498467},{"date":"2023-03-03","current":8.653867,"twenty":7.331113,"median":8.343913,"eighty":9.035515,"marketCap":31336413183},{"date":"2023-03-10","current":8.254337,"twenty":8.304196,"median":8.377747,"eighty":8.498491,"marketCap":29669060995},{"date":"2023-03-17","current":8.302888,"twenty":8.439491,"median":9.778189,"eighty":12.906031,"marketCap":30796975710},{"date":"2023-03-24","current":7.973363,"twenty":8.413431,"median":9.766198,"eighty":12.820464,"marketCap":29914259846},{"date":"2023-03-31","current":8.166454,"twenty":8.395776,"median":9.731127,"eighty":12.780132,"marketCap":30404657548},{"date":"2023-04-06","current":8.303527,"twenty":8.388577,"median":9.701824,"eighty":12.74706,"marketCap":30895055251},{"date":"2023-04-14","current":8.861526,"twenty":8.384572,"median":9.664439,"eighty":12.653705,"marketCap":33003765371},{"date":"2023-04-21","current":8.87926,"twenty":8.384572,"median":9.654518,"eighty":12.583515,"marketCap":33052805141},{"date":"2023-04-28","current":8.627323,"twenty":8.384572,"median":9.614125,"eighty":12.512289,"marketCap":31875850656},{"date":"2023-05-05","current":8.732458,"twenty":8.384572,"median":9.555834,"eighty":12.491124,"marketCap":32317208588},{"date":"2023-05-12","current":8.379376,"twenty":8.379852,"median":9.538827,"eighty":12.408353,"marketCap":30796975710},{"date":"2023-05-19","current":8.471818,"twenty":8.370776,"median":9.487625,"eighty":12.330627,"marketCap":30698896170},{"date":"2023-05-25","current":8.112738,"twenty":8.352853,"median":9.475751,"eighty":12.237909,"marketCap":29276742833},{"date":"2023-06-02","current":7.840362,"twenty":8.335337,"median":9.436109,"eighty":12.175745,"marketCap":28197867888},{"date":"2023-06-09","current":8.234033,"twenty":8.324782,"median":9.423192,"eighty":12.11971,"marketCap":29570981454},{"date":"2023-06-16","current":8.959698,"twenty":8.319797,"median":9.388812,"eighty":12.085094,"marketCap":32022969966},{"date":"2023-06-23","current":8.608748,"twenty":8.319797,"median":9.365367,"eighty":12.063817,"marketCap":30600816629},{"date":"2023-06-30","current":8.88224,"twenty":8.319797,"median":9.346704,"eighty":12.033442,"marketCap":31287373413},{"date":"2023-07-07","current":8.271887,"twenty":8.316547,"median":9.323187,"eighty":11.976397,"marketCap":29080583752},{"date":"2023-07-14","current":8.322493,"twenty":8.310549,"median":9.309265,"eighty":11.929637,"marketCap":29669060995},{"date":"2023-07-21","current":8.430454,"twenty":8.307062,"median":9.287219,"eighty":11.843438,"marketCap":29914259846},{"date":"2023-07-28","current":8.86838,"twenty":8.307062,"median":9.276824,"eighty":11.764904,"marketCap":31434492723},{"date":"2023-08-04","current":8.936536,"twenty":8.307062,"median":9.262566,"eighty":11.716239,"marketCap":31728731345},{"date":"2023-08-11","current":7.667665,"twenty":8.298794,"median":9.250609,"eighty":11.66957,"marketCap":27069953172},{"date":"2023-08-18","current":7.680986,"twenty":8.277128,"median":9.233781,"eighty":11.624073,"marketCap":26922833861},{"date":"2023-08-25","current":7.83102,"twenty":8.263548,"median":9.205782,"eighty":11.586986,"marketCap":27462271334},{"date":"2023-09-01","current":7.597057,"twenty":8.246014,"median":9.18368,"eighty":11.512091,"marketCap":27756509955},{"date":"2023-09-08","current":7.823382,"twenty":8.222375,"median":9.162103,"eighty":11.448566,"marketCap":28246907658},{"date":"2023-09-15","current":7.763189,"twenty":8.208739,"median":9.157406,"eighty":11.433841,"marketCap":28246907658},{"date":"2023-09-22","current":7.905576,"twenty":8.19994,"median":9.144778,"eighty":11.379603,"marketCap":28639225820},{"date":"2023-09-29","current":8.013665,"twenty":8.17663,"median":9.128087,"eighty":11.316082,"marketCap":29080583752},{"date":"2023-10-06","current":8.058065,"twenty":8.150863,"median":9.114013,"eighty":11.283535,"marketCap":29227703063},{"date":"2023-10-13","current":8.219065,"twenty":8.149541,"median":9.09274,"eighty":11.276664,"marketCap":29767140535},{"date":"2023-10-20","current":7.702855,"twenty":8.147937,"median":9.077658,"eighty":11.275061,"marketCap":27854589496},{"date":"2023-10-27","current":8.126744,"twenty":8.139474,"median":9.067852,"eighty":11.274008,"marketCap":29374822373},{"date":"2023-11-03","current":8.862973,"twenty":8.139474,"median":9.05336,"eighty":11.235912,"marketCap":32121049507},{"date":"2023-11-10","current":8.837757,"twenty":8.139474,"median":9.040401,"eighty":11.196418,"marketCap":32022969966},{"date":"2023-11-17","current":9.147742,"twenty":8.139474,"median":9.037721,"eighty":11.17851,"marketCap":33445123303},{"date":"2023-11-24","current":9.325816,"twenty":8.139474,"median":9.037721,"eighty":11.129796,"marketCap":34376878938},{"date":"2023-12-01","current":9.93649,"twenty":8.139474,"median":9.037721,"eighty":11.129796,"marketCap":36779827680},{"date":"2023-12-08","current":9.045644,"twenty":8.139474,"median":9.037721,"eighty":11.129796,"marketCap":33347043763},{"date":"2023-12-15","current":9.364038,"twenty":8.139474,"median":9.045644,"eighty":11.129796,"marketCap":34720157329},{"date":"2023-12-22","current":8.94678,"twenty":8.139474,"median":9.047199,"eighty":11.129796,"marketCap":33150884682},{"date":"2023-12-29","current":9.109965,"twenty":8.139474,"median":9.05336,"eighty":11.129796,"marketCap":33935521006},{"date":"2024-01-05","current":8.644343,"twenty":8.140631,"median":9.05336,"eighty":11.129796,"marketCap":31973930196},{"date":"2024-01-12","current":8.507232,"twenty":8.140631,"median":9.05336,"eighty":11.129796,"marketCap":31483532494},{"date":"2024-01-19","current":7.775849,"twenty":8.134001,"median":9.05336,"eighty":11.129796,"marketCap":28737305360},{"date":"2024-01-26","current":7.872836,"twenty":8.125459,"median":9.041452,"eighty":11.129796,"marketCap":28982504211},{"date":"2024-02-02","current":7.509416,"twenty":8.100103,"median":9.040115,"eighty":11.129796,"marketCap":27609390645},{"date":"2024-02-09","current":7.645163,"twenty":8.063219,"median":9.036052,"eighty":11.12591,"marketCap":28246907658},{"date":"2024-02-16","current":7.988529,"twenty":8.046861,"median":9.031921,"eighty":11.128149,"marketCap":29521941684},{"date":"2024-02-23","current":8.537797,"twenty":8.04613,"median":9.016525,"eighty":11.128149,"marketCap":31385452953},{"date":"2024-03-01","current":8.492479,"twenty":8.046276,"median":9.003163,"eighty":11.12703,"marketCap":31238333642},{"date":"2024-03-08","current":8.235509,"twenty":8.046276,"median":8.998085,"eighty":11.12703,"marketCap":30306578008},{"date":"2024-03-15","current":8.202792,"twenty":8.046276,"median":8.984294,"eighty":11.12703,"marketCap":30159458697},{"date":"2024-03-22","current":8.250352,"twenty":8.046276,"median":8.975491,"eighty":11.12703,"marketCap":30306578008},{"date":"2024-03-28","current":7.754906,"twenty":8.027776,"median":8.975491,"eighty":11.12703,"marketCap":20155345568},{"date":"2024-04-05","current":7.1617,"twenty":8.018579,"median":8.974975,"eighty":11.131442,"marketCap":18607980691},{"date":"2024-04-12","current":6.814957,"twenty":8.006911,"median":8.966131,"eighty":11.129796,"marketCap":17717104212},{"date":"2024-04-19","current":6.577064,"twenty":7.993388,"median":8.966131,"eighty":11.129796,"marketCap":17084049584},{"date":"2024-04-26","current":6.770418,"twenty":7.984307,"median":8.964299,"eighty":11.12703,"marketCap":17564605286},{"date":"2024-05-03","current":6.935068,"twenty":7.965221,"median":8.964299,"eighty":11.12703,"marketCap":17979325133},{"date":"2024-05-10","current":7.219046,"twenty":7.962199,"median":8.964299,"eighty":11.12703,"marketCap":18759974257},{"date":"2024-05-17","current":6.750187,"twenty":7.962199,"median":8.964299,"eighty":11.12703,"marketCap":17515814716},{"date":"2024-05-24","current":6.31334,"twenty":7.962199,"median":8.964299,"eighty":11.12703,"marketCap":16344841030},{"date":"2024-05-31","current":6.222201,"twenty":7.9387,"median":8.964299,"eighty":11.12703,"marketCap":16125283464},{"date":"2024-06-07","current":6.917952,"twenty":7.928416,"median":8.964299,"eighty":11.12703,"marketCap":17906139278},{"date":"2024-06-14","current":6.782791,"twenty":7.928416,"median":8.964299,"eighty":11.12703,"marketCap":17540210001},{"date":"2024-06-21","current":6.560685,"twenty":7.921282,"median":8.964299,"eighty":11.12703,"marketCap":16930327873},{"date":"2024-06-28","current":6.260772,"twenty":7.908744,"median":8.964299,"eighty":11.12703,"marketCap":16149678749},{"date":"2024-07-05","current":6.337808,"twenty":7.894477,"median":8.964299,"eighty":11.12703,"marketCap":16344841030},{"date":"2024-07-12","current":6.243502,"twenty":7.879477,"median":8.964299,"eighty":11.12703,"marketCap":16125283464},{"date":"2024-07-19","current":6.177268,"twenty":7.860032,"median":8.957851,"eighty":11.12703,"marketCap":15954516468},{"date":"2024-07-26","current":6.032068,"twenty":7.842934,"median":8.94678,"eighty":11.12703,"marketCap":15637377761},{"date":"2024-08-02","current":6.233318,"twenty":7.833873,"median":8.94678,"eighty":11.12703,"marketCap":16149678749},{"date":"2024-08-09","current":6.238818,"twenty":7.823631,"median":8.94678,"eighty":11.12703,"marketCap":16271655175},{"date":"2024-08-16","current":11.673892,"twenty":7.809026,"median":8.948265,"eighty":11.134735,"marketCap":17637791141},{"date":"2024-08-23","current":11.126325,"twenty":7.81089,"median":8.955567,"eighty":11.181206,"marketCap":16881537303},{"date":"2024-08-30","current":11.371553,"twenty":7.81089,"median":8.955567,"eighty":11.222898,"marketCap":17369443005},{"date":"2024-09-06","current":11.258922,"twenty":7.81089,"median":8.955567,"eighty":11.27078,"marketCap":17205686480},{"date":"2024-09-13","current":11.875091,"twenty":7.81089,"median":8.955567,"eighty":11.282869,"marketCap":18099802210},{"date":"2024-09-20","current":12.324384,"twenty":7.809714,"median":8.952069,"eighty":11.30903,"marketCap":18897256780},{"date":"2024-09-27","current":13.080998,"twenty":7.809714,"median":8.952069,"eighty":11.354051,"marketCap":20178017150},{"date":"2024-10-04","current":15.768825,"twenty":7.809714,"median":8.952069,"eighty":11.376678,"marketCap":24213620580},{"date":"2024-10-10","current":14.408555,"twenty":7.81089,"median":8.955567,"eighty":11.404726,"marketCap":21990413900},{"date":"2024-10-18","current":13.980342,"twenty":7.809714,"median":8.952069,"eighty":11.437655,"marketCap":21217124620},{"date":"2024-10-25","current":13.121335,"twenty":7.809714,"median":8.952069,"eighty":11.46738,"marketCap":19912198960},{"date":"2024-11-01","current":12.53962,"twenty":7.809714,"median":8.952069,"eighty":11.46738,"marketCap":19042248520},{"date":"2024-11-08","current":12.644718,"twenty":7.809714,"median":8.952069,"eighty":11.473153,"marketCap":19114744390},{"date":"2024-11-15","current":12.295345,"twenty":7.809714,"median":8.952069,"eighty":11.473153,"marketCap":18389785690},{"date":"2024-11-22","current":11.882105,"twenty":7.809714,"median":8.952069,"eighty":11.473153,"marketCap":17761488150},{"date":"2024-11-29","current":12.665285,"twenty":7.809714,"median":8.952069,"eighty":11.473153,"marketCap":18921422070},{"date":"2024-12-06","current":12.743827,"twenty":7.809714,"median":8.952069,"eighty":11.473153,"marketCap":18993917940},{"date":"2024-12-13","current":12.249171,"twenty":7.809714,"median":8.952069,"eighty":11.473153,"marketCap":18220628660},{"date":"2024-12-20","current":12.091557,"twenty":7.809714,"median":8.952069,"eighty":11.473153,"marketCap":17906479890},{"date":"2024-12-27","current":12.280582,"twenty":7.809714,"median":8.952069,"eighty":11.473153,"marketCap":18172298080},{"date":"2025-01-03","current":11.697559,"twenty":7.809714,"median":8.952069,"eighty":11.473153,"marketCap":17326512930},{"date":"2025-01-10","current":11.69292,"twenty":7.809714,"median":8.952069,"eighty":11.51924,"marketCap":17254017060},{"date":"2025-01-17","current":11.405313,"twenty":7.809714,"median":8.952069,"eighty":11.51924,"marketCap":16843207130},{"date":"2025-01-24","current":11.496909,"twenty":7.809714,"median":8.952069,"eighty":11.496909,"marketCap":17084860030},{"date":"2025-01-28","current":11.356087,"twenty":7.81089,"median":8.955567,"eighty":11.496126,"marketCap":16964033580},{"date":"2025-02-07","current":12.348026,"twenty":7.809542,"median":8.948571,"eighty":11.51924,"marketCap":18341455110},{"date":"2025-02-14","current":12.565576,"twenty":7.809542,"median":8.948571,"eighty":11.58651,"marketCap":18655603880},{"date":"2025-02-21","current":13.461607,"twenty":7.809542,"median":8.948571,"eighty":11.607936,"marketCap":20057190700},{"date":"2025-02-28","current":13.359667,"twenty":7.809542,"median":8.948571,"eighty":11.655773,"marketCap":19839703090},{"date":"2025-03-07","current":12.722778,"twenty":7.80937,"median":8.948418,"eighty":11.706046,"marketCap":18969752650},{"date":"2025-03-14","current":13.657836,"twenty":7.80937,"median":8.948418,"eighty":11.729294,"marketCap":20371339470},{"date":"2025-03-21","current":10.743697,"twenty":7.80937,"median":8.958246,"eighty":11.782524,"marketCap":18662396850},{"date":"2025-03-28","current":11.131367,"twenty":7.80937,"median":8.960038,"eighty":11.782524,"marketCap":19296674390},{"date":"2025-04-03","current":11.675111,"twenty":7.80937,"median":8.960038,"eighty":11.782524,"marketCap":20199300120},{"date":"2025-04-11","current":10.16599,"twenty":7.80937,"median":8.960038,"eighty":11.782524,"marketCap":17471504670},{"date":"2025-04-17","current":10.321045,"twenty":7.809542,"median":8.960379,"eighty":11.773743,"marketCap":17761488150},{"date":"2025-04-25","current":11.954871,"twenty":7.809198,"median":8.959698,"eighty":11.87428,"marketCap":20612992370},{"date":"2025-05-02","current":11.663793,"twenty":7.80937,"median":8.960038,"eighty":11.873875,"marketCap":20153851860},{"date":"2025-05-09","current":11.582483,"twenty":7.809198,"median":8.959698,"eighty":11.87428,"marketCap":20153851860},{"date":"2025-05-16","current":11.350869,"twenty":7.809198,"median":8.959698,"eighty":11.87428,"marketCap":19912198960},{"date":"2025-05-23","current":14.118803,"twenty":7.809198,"median":8.959698,"eighty":11.934123,"marketCap":24841918120},{"date":"2025-05-30","current":14.658663,"twenty":7.809198,"median":8.959698,"eighty":11.976986,"marketCap":25905190880},{"date":"2025-06-06","current":14.566803,"twenty":7.809198,"median":8.959698,"eighty":12.043121,"marketCap":25808529720},{"date":"2025-06-13","current":15.433618,"twenty":7.809198,"median":8.959698,"eighty":12.077209,"marketCap":27355108280},{"date":"2025-06-20","current":15.846428,"twenty":7.809198,"median":8.959698,"eighty":12.127263,"marketCap":28031736400},{"date":"2025-06-27","current":16.347079,"twenty":7.80937,"median":8.960038,"eighty":12.2108,"marketCap":28998348000},{"date":"2025-07-04","current":16.673233,"twenty":7.80937,"median":8.960038,"eighty":12.252742,"marketCap":29578308986},{"date":"2025-07-11","current":16.744588,"twenty":7.80937,"median":8.960038,"eighty":12.297631,"marketCap":29674970127},{"date":"2025-07-18","current":18.258819,"twenty":7.80937,"median":8.960038,"eighty":12.329361,"marketCap":32333151490},{"date":"2025-07-25","current":18.19266,"twenty":7.80937,"median":8.960038,"eighty":12.355651,"marketCap":32333151490},{"date":"2025-08-01","current":17.785876,"twenty":7.80937,"median":8.960038,"eighty":12.435118,"marketCap":31414870656},{"date":"2025-08-08","current":18.150915,"twenty":7.80937,"median":8.960038,"eighty":12.486153,"marketCap":32139829209},{"date":"2025-08-15","current":18.451509,"twenty":7.80937,"median":8.960038,"eighty":12.51282,"marketCap":32623134912},{"date":"2025-08-22","current":18.083959,"twenty":7.80937,"median":8.960038,"eighty":12.54414,"marketCap":32478143201},{"date":"2025-08-29","current":17.515947,"twenty":7.80937,"median":8.960038,"eighty":12.608694,"marketCap":31608192936},{"date":"2025-09-05","current":18.297389,"twenty":7.80937,"median":8.960038,"eighty":12.660112,"marketCap":32985614188},{"date":"2025-09-12","current":20.673017,"twenty":7.80937,"median":8.960038,"eighty":12.731198,"marketCap":37335365510},{"date":"2025-09-19","current":20.111924,"twenty":7.80937,"median":8.960038,"eighty":12.818774,"marketCap":36296258250},{"date":"2025-09-26","current":19.117097,"twenty":7.80937,"median":8.960038,"eighty":12.92804,"marketCap":34411366010},{"date":"2025-10-03","current":18.897472,"twenty":7.809542,"median":8.964299,"eighty":12.973709,"marketCap":34097217304},{"date":"2025-10-10","current":18.670211,"twenty":7.80937,"median":8.973484,"eighty":13.021101,"marketCap":33638076887},{"date":"2025-10-17","current":17.624343,"twenty":7.80937,"median":8.982986,"eighty":13.089837,"marketCap":31729019362},{"date":"2025-10-24","current":17.577683,"twenty":7.80937,"median":9.001051,"eighty":13.137117,"marketCap":31656523507},{"date":"2025-10-31","current":17.993641,"twenty":7.80937,"median":9.004755,"eighty":13.194762,"marketCap":32453977916},{"date":"2025-11-07","current":18.836089,"twenty":7.80937,"median":9.023956,"eighty":13.281103,"marketCap":33952225593},{"date":"2025-11-14","current":18.769496,"twenty":7.80937,"median":9.036052,"eighty":13.335158,"marketCap":33928060308},{"date":"2025-11-21","current":17.521012,"twenty":7.80937,"median":9.040926,"eighty":13.484236,"marketCap":31656523507},{"date":"2025-11-28","current":17.724128,"twenty":7.80937,"median":9.0538,"eighty":13.552628,"marketCap":32139829209},{"date":"2025-12-05","current":17.919868,"twenty":7.80937,"median":9.069322,"eighty":13.597963,"marketCap":32550639056},{"date":"2025-12-12","current":18.019573,"twenty":7.820266,"median":9.111248,"eighty":13.68318,"marketCap":32792291907},{"date":"2025-12-19","current":17.606268,"twenty":7.82402,"median":9.136646,"eighty":13.705161,"marketCap":32115663924},{"date":"2025-12-24","current":17.247846,"twenty":7.82402,"median":9.146714,"eighty":13.737638,"marketCap":31559862366},{"date":"2026-01-02","current":17.246004,"twenty":7.823825,"median":9.160035,"eighty":13.809666,"marketCap":31680688792},{"date":"2026-01-09","current":18.633486,"twenty":7.823825,"median":9.161853,"eighty":13.870372,"marketCap":34314704870},{"date":"2026-01-16","current":18.337696,"twenty":7.823825,"median":9.176287,"eighty":13.991045,"marketCap":33879729738},{"date":"2026-01-23","current":17.975631,"twenty":7.823825,"median":9.176287,"eighty":14.04138,"marketCap":33178936469},{"date":"2026-01-30","current":18.284809,"twenty":7.823825,"median":9.176287,"eighty":14.11679,"marketCap":33903895023},{"date":"2026-02-06","current":19.811509,"twenty":7.823825,"median":9.176287,"eighty":14.189418,"marketCap":36827894522},{"date":"2026-02-13","current":19.556185,"twenty":7.82402,"median":9.184397,"eighty":14.282216,"marketCap":36562076386},{"date":"2026-02-20","current":19.597337,"twenty":7.823631,"median":9.172521,"eighty":14.320757,"marketCap":36586241671},{"date":"2026-02-27","current":18.693346,"twenty":7.823631,"median":9.172521,"eighty":14.410499,"marketCap":35281316275},{"date":"2026-03-06","current":17.038189,"twenty":7.823631,"median":9.172521,"eighty":14.640685,"marketCap":31898176358},{"date":"2026-03-13","current":16.330497,"twenty":7.823631,"median":9.172521,"eighty":14.699644,"marketCap":30714077387},{"date":"2026-03-20","current":19.319228,"twenty":7.823631,"median":9.172521,"eighty":14.829651,"marketCap":32652571980},{"date":"2026-03-25","current":19.04479,"twenty":7.823631,"median":9.172521,"eighty":14.901444,"marketCap":32120061540}],"updateTime":1774518196099},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"00867\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1170166677","title":"CICC Maintains \"Outperform\" Rating on CMS (00867), Raises Target Price to HK$16.5","url":"https://stock-news.laohu8.com/highlight/detail?id=1170166677","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170166677?lang=en_us&edition=fundamental","pubTime":"2026-02-02 09:28","pubTimestamp":1769995710,"startTime":"0","endTime":"0","summary":"CICC has reaffirmed its \"Outperform\" rating on CMS (00867) and increased its target price by 7% to HK$16.50, citing a sector-wide upward trend in valuation benchmarks. The firm has maintained its...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","SG9999015952.SGD","IE00BVYPNQ40.USD","SG9999015986.USD","00867","IE00BMCWC346.EUR","BK1593","IE00BVYPNP33.GBP","LU2488822045.USD","SG9999015978.USD","SG9999004220.SGD","IE00BYV24P56.USD","IE00BGHQDM52.EUR","BK1191"],"gpt_icon":0},{"id":"2607725014","title":"China Medical System Holdings Limited Approval of Clinical Trials for Pnh of Innovative Drug Complement Factor B Inhibitor CMS-D017","url":"https://stock-news.laohu8.com/highlight/detail?id=2607725014","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607725014?lang=en_us&edition=fundamental","pubTime":"2026-01-30 19:27","pubTimestamp":1769772461,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUE7MDNYJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BVYPNQ40.USD","SG9999015952.SGD","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","SG9999015986.USD","IE00BVYPNP33.GBP","00867","BK1191","BK1593","SG9999004220.SGD","SG9999015978.USD","IE00BYV24P56.USD","LU2488822045.USD","SG9999015945.SGD"],"gpt_icon":0},{"id":"2607144080","title":"China Medical System - CMS-D017 Capsules Obtain Drug Clinical Trial Approval From Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2607144080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607144080?lang=en_us&edition=fundamental","pubTime":"2026-01-30 19:20","pubTimestamp":1769772030,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nFWN3YV0IN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015945.SGD","BK1191","IE00BGHQDM52.EUR","BK1593","SG9999015978.USD","SG9999015952.SGD","00867","IE00BMCWC346.EUR","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","SG9999004220.SGD","IE00BYV24P56.USD","LU2488822045.USD","SG9999015986.USD"],"gpt_icon":0},{"id":"2607144040","title":"China Medical System Holdings Receives NMPA Approval to Begin Clinical Trials for CMS-D017","url":"https://stock-news.laohu8.com/highlight/detail?id=2607144040","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607144040?lang=en_us&edition=fundamental","pubTime":"2026-01-30 19:20","pubTimestamp":1769772023,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited announced that its self-developed innovative drug, CMS-D017, a novel selective small-molecule inhibitor of complement factor B, has received Drug Clinical Trial Approval from the National Medical Products Administration  of China. The approval allows the company to conduct clinical trials in healthy participants in China to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of CMS-D017, which is being developed for the treatment of paroxysmal nocturnal hemoglobinuria . The company is actively preparing to initiate the relevant clinical trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDLkY9YH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYV24P56.USD","SG9999015978.USD","BK1593","IE00BMCWC346.EUR","BK1191","IE00BGHQDM52.EUR","00867","SG9999004220.SGD","SG9999015952.SGD","SG9999015986.USD","IE00BVYPNQ40.USD","SG9999015945.SGD","IE00BVYPNP33.GBP","LU2488822045.USD"],"gpt_icon":0},{"id":"2607098054","title":"China Medical System Unit Secures New Drug Application Approval in China for Vitiligo Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2607098054","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607098054?lang=en_us&edition=fundamental","pubTime":"2026-01-30 13:44","pubTimestamp":1769751848,"startTime":"0","endTime":"0","summary":"China Medical System  said its unit Dermavon secured approval from China's National Medical Products Administration for the New Drug Application of ruxolitinib phosphate cream, according to a Friday Hong Kong bourse filing.The drug is approved to treat non-segmental vitiligo with facial involvement in patients aged 12 and above, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BGHQDM52.EUR","LU2488822045.USD","IE00BMCWC346.EUR","BK1191","IE00BVYPNP33.GBP","SG9999015978.USD","BK1593","IE00BVYPNQ40.USD","SG9999004220.SGD","SG9999015952.SGD","IE00BYV24P56.USD","SG9999015986.USD","00867","SG9999015945.SGD"],"gpt_icon":0},{"id":"1192355574","title":"CMS (00867): Innovative Drug Ruxolitinib Phosphate Cream Approved in China, Marking First and Only Targeted Therapy for Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=1192355574","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192355574?lang=en_us&edition=fundamental","pubTime":"2026-01-30 12:20","pubTimestamp":1769746818,"startTime":"0","endTime":"0","summary":"CMS (00867) announced that its subsidiary, Demai Pharmaceutical Co., Ltd. (\"Demai Pharma,\" an innovative pharmaceutical company specializing in dermatological health that is applying for an...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","159992","IE00BVYPNQ40.USD","SG9999004220.SGD","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP","IE00BYV24P56.USD","LU2488822045.USD","06978","SG9999015978.USD","SG9999015986.USD","BK1191","00867","SG9999015952.SGD","BK1161","IE00BMCWC346.EUR","BK1593","BK1574"],"gpt_icon":0},{"id":"2607067810","title":"China Medical System Holdings - New Drug Application of Ruxolitinib Phosphate Cream Approved in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2607067810","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607067810?lang=en_us&edition=fundamental","pubTime":"2026-01-30 12:08","pubTimestamp":1769746111,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nFWN3YV009:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","BK1191","LU2488822045.USD","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","SG9999015945.SGD","SG9999015952.SGD","00867","IE00BYV24P56.USD","SG9999004220.SGD","SG9999015986.USD","SG9999015978.USD","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP"],"gpt_icon":0},{"id":"2607406784","title":"China Medical System Holdings Wins NMPA Approval for Ruxolitinib Cream for Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=2607406784","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607406784?lang=en_us&edition=fundamental","pubTime":"2026-01-30 12:08","pubTimestamp":1769746106,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Ltd. announced that its subsidiary, Dermavon Holdings Limited, has received approval from the National Medical Products Administration of China  for the New Drug Application  of ruxolitinib phosphate cream. The approved indication is for the treatment of non-segmental vitiligo with facial involvement in children aged 12 years and older and adult patients. This is the first and only targeted drug approved in China for vitiligo, addressing a significant unmet clinical need.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on Janua","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDLbCmfj6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","IE00BYV24P56.USD","BK1593","SG9999004220.SGD","IE00BMCWC346.EUR","BK1191","00867","IE00BVYPNP33.GBP","SG9999015952.SGD","IE00BVYPNQ40.USD","SG9999015945.SGD","SG9999015978.USD","SG9999015986.USD","IE00BGHQDM52.EUR"],"gpt_icon":0},{"id":"2607779991","title":"With 51% ownership, China Medical System Holdings Limited (HKG:867) insiders have a lot riding on the company's future","url":"https://stock-news.laohu8.com/highlight/detail?id=2607779991","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607779991?lang=en_us&edition=fundamental","pubTime":"2026-01-29 07:17","pubTimestamp":1769642263,"startTime":"0","endTime":"0","summary":"Key Insights Significant insider control over China Medical System Holdings implies vested interests in company growth...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/with-51-ownership-china-medical-system-holdings-limited-hkg8","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/with-51-ownership-china-medical-system-holdings-limited-hkg8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999015945.SGD","IE00BYV24P56.USD","LU2488822045.USD","SG9999015978.USD","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","SG9999015986.USD","IE00BGHQDM52.EUR","00867","SG9999015952.SGD","BK1191","SG9999004220.SGD","BK1593"],"gpt_icon":0},{"id":"1128251180","title":"CMS Securities Initiates Coverage on CMS (00867) with \"Strongly Recommend\" Rating, Citing Innovation and Internationalization Driving Commercial Leader into New Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=1128251180","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128251180?lang=en_us&edition=fundamental","pubTime":"2026-01-21 09:48","pubTimestamp":1768960118,"startTime":"0","endTime":"0","summary":"CMS Securities released a research report initiating coverage on CMS (00867) with a \"Strongly Recommend\" rating. The institution believes the impact of centralized drug procurement on the company's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","SG9999015978.USD","BK1147","BK1191","BK1564","IE00BGHQDM52.EUR","00867","IE00BYV24P56.USD","SG9999004220.SGD","BK1593","IE00BMCWC346.EUR","IE00BVYPNP33.GBP","SG9999015945.SGD","06099","LU2488822045.USD","SG9999015986.USD","IE00BVYPNQ40.USD"],"gpt_icon":0},{"id":"2601685334","title":"An Insider At China Medical System Holdings Lowered Their Holding Recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2601685334","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601685334?lang=en_us&edition=fundamental","pubTime":"2026-01-08 07:10","pubTimestamp":1767827456,"startTime":"0","endTime":"0","summary":"Viewing insider transactions for China Medical System Holdings Limited's ( HKG:867 ) over the last year, we see that...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/an-insider-at-china-medical-system-holdings-lowered-their-ho","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/an-insider-at-china-medical-system-holdings-lowered-their-ho","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BYV24P56.USD","SG9999015978.USD","BK1593","IE00BMCWC346.EUR","BK1191","IE00BGHQDM52.EUR","00867","SG9999004220.SGD","SG9999015952.SGD","SG9999015986.USD","IE00BVYPNQ40.USD","SG9999015945.SGD","IE00BVYPNP33.GBP","LU2488822045.USD"],"gpt_icon":0},{"id":"2592891022","title":"China Medical System Holdings (SEHK:867): Valuation Check After Y-3 Stroke Drug NDA Acceptance and Phase III Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2592891022","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592891022?lang=en_us&edition=fundamental","pubTime":"2025-12-17 18:34","pubTimestamp":1765967650,"startTime":"0","endTime":"0","summary":"China Medical System Holdings (SEHK:867) just cleared a meaningful hurdle, with regulators accepting its New Drug Application for Y-3 for Injection after a successful Phase III trial in acute ischemic stroke patients.\nSee our latest analysis for China Medical System Holdings.\nDespite a softer 30 day share price return and some recent consolidation, China Medical System Holdings still sits at HK$13.40, with strong upward share price return year to date and a robust multi year total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-sehk867-valuation-check-after","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-sehk867-valuation-check-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00867","BK4134","SG9999015952.SGD","SG9999015945.SGD","BK1191","SG9999015978.USD","III","IE00BVYPNP33.GBP","BK1593","SG9999004220.SGD","IE00BVYPNQ40.USD","DCF","LU2488822045.USD","IE00BMCWC346.EUR","SG9999015986.USD","IE00BGHQDM52.EUR","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"1164514638","title":"Guoyuan International Initiates \"Buy\" Rating on CMS (00867) with Target Price of HK$17.68","url":"https://stock-news.laohu8.com/highlight/detail?id=1164514638","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164514638?lang=en_us&edition=fundamental","pubTime":"2025-12-17 14:44","pubTimestamp":1765953876,"startTime":"0","endTime":"0","summary":"Guoyuan International released a research report highlighting that CMS (00867) has established a global pipeline of 40 innovative drugs, primarily featuring First-in-Class (FIC) and Best-in-Class...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004220.SGD","SG9999015945.SGD","IE00BVYPNQ40.USD","BK1593","SG9999015978.USD","IE00BGHQDM52.EUR","00867","IE00BYV24P56.USD","SG9999015986.USD","BK1191","IE00BVYPNP33.GBP","SG9999015952.SGD","IE00BMCWC346.EUR","LU2488822045.USD"],"gpt_icon":0},{"id":"2591641369","title":"Dermavon Secures Breakthrough Drug Status for Oral JAK1 Inhibitor in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2591641369","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591641369?lang=en_us&edition=fundamental","pubTime":"2025-12-15 21:19","pubTimestamp":1765804781,"startTime":"0","endTime":"0","summary":"Dermavon, a China Medical System Holdings Ltd. Subsidiary, Gains Breakthrough Drug Status in China for Oral JAK1 Inhibitor Povorcitinib. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire  on December 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL3jH6N4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK1593","SG9999014005.SGD","00867","IE00BYV24P56.USD","SG9999014021.USD","BK4588","IE00BMCWC346.EUR","BK4112","NDAQ","SG9999015952.SGD","BK1191","SG9999014013.SGD","SG9999004220.SGD","SG9999015978.USD","SG9999014039.USD","LU2488822045.USD","LU2210149790.SGD","SG9999015986.USD","IE00BGHQDM52.EUR","SG9999015945.SGD","IE00BKPKM429.USD","BK4585","LU0314104364.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2095319765.USD","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD"],"gpt_icon":0},{"id":"1107899930","title":"CMS (00867): Innovative Oral JAK1 Inhibitor Povorcitinib Included in Breakthrough Therapy List","url":"https://stock-news.laohu8.com/highlight/detail?id=1107899930","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107899930?lang=en_us&edition=fundamental","pubTime":"2025-12-15 19:54","pubTimestamp":1765799662,"startTime":"0","endTime":"0","summary":"CMS (00867) announced that povorcitinib, an innovative oral JAK1 inhibitor (proposed Chinese generic name: phosphate povorcitinib tablets) with licensing rights held by its subsidiary Demai...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","SG9999015945.SGD","SG9999004220.SGD","06978","159992","IE00BVYPNQ40.USD","BK1161","SG9999015986.USD","LU2488822045.USD","00867","SG9999015952.SGD","SG9999015978.USD","IE00BMCWC346.EUR","BK1574","IE00BVYPNP33.GBP","BK1191","IE00BYV24P56.USD","IE00BGHQDM52.EUR"],"gpt_icon":0},{"id":"2591643410","title":"China Medical System's Povorcitinib Listed as Breakthrough Therapeutic Drug by China NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2591643410","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591643410?lang=en_us&edition=fundamental","pubTime":"2025-12-15 19:43","pubTimestamp":1765799018,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Ltd. announced that its subsidiary, Dermavon Holdings Limited, has obtained regulatory recognition for its innovative oral JAK1 inhibitor, povorcitinib. The drug has been included in the list of Breakthrough Therapeutic Drugs by the Center for Drug Evaluation of the National Medical Products Administration of China, with a proposed indication for adult patients with non-segmental vitiligo. This designation is expected to accelerate the development and review process of povorcitinib.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL55pJRd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004220.SGD","SG9999015945.SGD","IE00BVYPNQ40.USD","BK1593","SG9999015978.USD","IE00BGHQDM52.EUR","00867","IE00BYV24P56.USD","SG9999015986.USD","BK1191","IE00BVYPNP33.GBP","SG9999015952.SGD","IE00BMCWC346.EUR","LU2488822045.USD"],"gpt_icon":0},{"id":"2591661359","title":"What China Medical System Holdings (SEHK:867)'s Stroke Drug NDA Acceptance Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2591661359","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591661359?lang=en_us&edition=fundamental","pubTime":"2025-12-14 17:17","pubTimestamp":1765703856,"startTime":"0","endTime":"0","summary":"On 11 December 2025, China Medical System Holdings announced that China’s National Medical Products Administration accepted the New Drug Application for Y-3 (Loberamisal) for Injection, a Class 1 innovative brain cytoprotectant for acute ischemic stroke based on PSD-95-nNOS and MPO targets.\nThis first-in-class, multi-target therapy addresses both stroke damage and post-stroke mood complications, positioning the company more firmly in China’s large and complex cerebrovascular disease...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/what-china-medical-system-holdings-sehk867s-stroke-drug-nda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/what-china-medical-system-holdings-sehk867s-stroke-drug-nda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BGHQDM52.EUR","IE00BYV24P56.USD","SG9999004220.SGD","IE00BVYPNP33.GBP","SG9999015945.SGD","IE00BMCWC346.EUR","BK1593","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015986.USD","00867","SG9999015978.USD","SG9999015952.SGD","BK1191"],"gpt_icon":0},{"id":"1113555991","title":"CMS (00867): China's NMPA Accepts New Drug Application for Class 1 Innovative Drug Y-3 Injection for Acute Ischemic Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=1113555991","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113555991?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:24","pubTimestamp":1765452271,"startTime":"0","endTime":"0","summary":"CMS (00867) announced that the New Drug Application (NDA) for its Class 1 innovative drug Y-3 Injection (proposed Chinese generic name: Lobe Miliu Injection) has been accepted by China's National...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867","LU2488822045.USD","IE00BMCWC346.EUR","SG9999015978.USD","IE00BYV24P56.USD","IE00BGHQDM52.EUR","SG9999015986.USD","SG9999004220.SGD","SG9999015952.SGD","SG9999015945.SGD","IE00BVYPNP33.GBP","BK1191","IE00BVYPNQ40.USD","BK1593"],"gpt_icon":0},{"id":"2590059704","title":"China Medical System -  Nda of Class 1 Innovative Drug Y-3 for Injection Accepted by China's Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2590059704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590059704?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:17","pubTimestamp":1765451876,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XH0KL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015986.USD","BK1593","00867","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","BK1191","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","SG9999015978.USD","IE00BYV24P56.USD","SG9999015952.SGD","SG9999015945.SGD","LU2488822045.USD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2590559702","title":"China Medical System's New Drug Application for Y-3 Injection Accepted in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2590559702","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590559702?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:17","pubTimestamp":1765451844,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Ltd. announced that the New Drug Application  for its Class 1 Innovative Drug Y-3 for Injection, intended for the treatment of acute ischemic stroke, has been accepted for review in China. The company entered into a collaboration agreement with Neurodawn Pharmaceutical Co., Ltd., granting China Medical System exclusive promotion rights for the product in mainland China, Hong Kong, and Macau. The acceptance of the NDA marks a significant regulatory milestone and is expected to positively impact the company's innovative drug portfolio in the central nervous system field.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDLyTdth:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQDM52.EUR","IE00BYV24P56.USD","SG9999004220.SGD","IE00BVYPNP33.GBP","SG9999015945.SGD","IE00BMCWC346.EUR","BK1593","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015986.USD","00867","SG9999015978.USD","SG9999015952.SGD","BK1191"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":109,"code":"91000000","status":"200"}]}}